We performed a hemodynamic assessment involving the measurement of regional cerebral blood flow (rCBF) and regional cerebral blood volume (rCBV) with single-photon-emitting isotopes in 75 patients with unilateral or bilateral carotid occlusions. rCBF was measured by following the clearance of inhaled 133Xe and rCBV by single-photon emission tomographic recording of the distribution of 99mTc-labeled autologous erythrocytes. Four patterns were observed, one of which appears to represent a state of hemodynamic compromise associated with an impaired hemodynamic reserve (HR) manifesting as compensatory vasodilation and impaired autoregulation to changes in PACO2. Impaired hemodynamics were noted in 27% of patients and in 35% of the 51 patients that would have been ''eligible'' for randomization in the extracranial-intracranial (ECIC) bypass study of Barnett et al. [Surg Neurol 1986;26:222–226]. Thirty-three patients thus ''eligible'' had normal HR and only 1 suffered a delayed stroke ipsilateral to an occluded artery in 21 months of follow-up. Eighteen ''eligible'' patients with impaired HR were also followed during a mean of 21 months. Fourteen of the patients with impaired HR underwent ECIC bypass and suffered a high (18%) perioperative morbidity and mortality; 4 were not operated upon, and 2 of these developed hemiplegia due to infarction ipsilateral to the ICA occlusion. We conclude that relatively few patients considered suitable for ECIC bypass on clinical and radiological grounds have an impaired HR which might justify revascularization. The clinical benefit of revascularization in those selected because of impaired hemodynamics remains to be demonstrated. In this context it appears from our small series that there is a high risk for surgery as well as spontaneous stroke in this population.

Keywords:
ECIC bypass, Cerebral blood flow, Cerebral blood volume, Hemodynamic reserve, Internal carotid occlusion
This content is only available via PDF.
© 1992 S. Karger AG, Basel
1992
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.